IT8521236A0 - Amminoacil derivati di 4(5)-imidazolidinoni ad attivita - Google Patents

Amminoacil derivati di 4(5)-imidazolidinoni ad attivita

Info

Publication number
IT8521236A0
IT8521236A0 IT8521236A IT2123685A IT8521236A0 IT 8521236 A0 IT8521236 A0 IT 8521236A0 IT 8521236 A IT8521236 A IT 8521236A IT 2123685 A IT2123685 A IT 2123685A IT 8521236 A0 IT8521236 A0 IT 8521236A0
Authority
IT
Italy
Prior art keywords
aminoacil
imidazolidinones
derivatives
activity
aminoacil derivatives
Prior art date
Application number
IT8521236A
Other languages
English (en)
Other versions
IT1222367B (it
Inventor
Mario Pinza
Ugo Pfeiffer
Carlo Farina
Silvano Banfi
Original Assignee
Isf Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isf Spa filed Critical Isf Spa
Publication of IT8521236A0 publication Critical patent/IT8521236A0/it
Priority to IT21236/85A priority Critical patent/IT1222367B/it
Priority to FI862422A priority patent/FI862422A/fi
Priority to ZA864446A priority patent/ZA864446B/xx
Priority to NZ216552A priority patent/NZ216552A/xx
Priority to AT86304650T priority patent/ATE56020T1/de
Priority to EP86304650A priority patent/EP0207680B1/en
Priority to IL79138A priority patent/IL79138A/xx
Priority to DE8686304650T priority patent/DE3673709D1/de
Priority to GR861578A priority patent/GR861578B/el
Priority to JP61144688A priority patent/JPH0688979B2/ja
Priority to CA000512111A priority patent/CA1273450A/en
Priority to PH33924A priority patent/PH23229A/en
Priority to US06/876,946 priority patent/US4703054A/en
Priority to DK290386A priority patent/DK290386A/da
Priority to KR1019860004922A priority patent/KR870000305A/ko
Priority to NO862487A priority patent/NO166409C/no
Priority to HU862610A priority patent/HUT41741A/hu
Priority to AU58917/86A priority patent/AU590283B2/en
Priority to PH35708A priority patent/PH24336A/en
Application granted granted Critical
Publication of IT1222367B publication Critical patent/IT1222367B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1024Tetrapeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Luminescent Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IT21236/85A 1985-06-21 1985-06-21 Amminoacil derivati di 4(5)-imidazolodinoni adattivita' nootropica:loro preparazione ed uso farmaceutico IT1222367B (it)

Priority Applications (19)

Application Number Priority Date Filing Date Title
IT21236/85A IT1222367B (it) 1985-06-21 1985-06-21 Amminoacil derivati di 4(5)-imidazolodinoni adattivita' nootropica:loro preparazione ed uso farmaceutico
FI862422A FI862422A (fi) 1985-06-21 1986-06-06 Kemiska blandningar.
ZA864446A ZA864446B (en) 1985-06-21 1986-06-13 Imidazolidinones and imidazolidines,process for the preparation and their use
NZ216552A NZ216552A (en) 1985-06-21 1986-06-16 Imidazoles and pharmaceutical compositions
AT86304650T ATE56020T1 (de) 1985-06-21 1986-06-17 Chemische verbindungen.
EP86304650A EP0207680B1 (en) 1985-06-21 1986-06-17 Chemical compounds
IL79138A IL79138A (en) 1985-06-21 1986-06-17 Substituted imidazolidinones,their preparation and pharmaceutical compositions containing them
DE8686304650T DE3673709D1 (de) 1985-06-21 1986-06-17 Chemische verbindungen.
GR861578A GR861578B (en) 1985-06-21 1986-06-18 Chemical compounds and preparation process therefor
JP61144688A JPH0688979B2 (ja) 1985-06-21 1986-06-20 化合物
CA000512111A CA1273450A (en) 1985-06-21 1986-06-20 Nootropic imidazolidinomes
PH33924A PH23229A (en) 1985-06-21 1986-06-20 Imidazolidinone and imidazolidine acetamide derivatives
US06/876,946 US4703054A (en) 1985-06-21 1986-06-20 Nootropic imidazolidinones
DK290386A DK290386A (da) 1985-06-21 1986-06-20 Imidazolidinforbindelse og fremgangsmaade til fremstilling deraf
KR1019860004922A KR870000305A (ko) 1985-06-21 1986-06-20 신규의 화학적 화합물의 제조방법
NO862487A NO166409C (no) 1985-06-21 1986-06-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser.
HU862610A HUT41741A (en) 1985-06-21 1986-06-20 Process for preparing new imidazolidinones and pharmaceutical compositions containing the new compounds
AU58917/86A AU590283B2 (en) 1985-06-21 1986-06-20 4(5)-imidazolidinone derivatives with nootropic activity
PH35708A PH24336A (en) 1985-06-21 1987-08-20 Process for preparing imidazolidine acetamide derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21236/85A IT1222367B (it) 1985-06-21 1985-06-21 Amminoacil derivati di 4(5)-imidazolodinoni adattivita' nootropica:loro preparazione ed uso farmaceutico

Publications (2)

Publication Number Publication Date
IT8521236A0 true IT8521236A0 (it) 1985-06-21
IT1222367B IT1222367B (it) 1990-09-05

Family

ID=11178826

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21236/85A IT1222367B (it) 1985-06-21 1985-06-21 Amminoacil derivati di 4(5)-imidazolodinoni adattivita' nootropica:loro preparazione ed uso farmaceutico

Country Status (18)

Country Link
US (1) US4703054A (it)
EP (1) EP0207680B1 (it)
JP (1) JPH0688979B2 (it)
KR (1) KR870000305A (it)
AT (1) ATE56020T1 (it)
AU (1) AU590283B2 (it)
CA (1) CA1273450A (it)
DE (1) DE3673709D1 (it)
DK (1) DK290386A (it)
FI (1) FI862422A (it)
GR (1) GR861578B (it)
HU (1) HUT41741A (it)
IL (1) IL79138A (it)
IT (1) IT1222367B (it)
NO (1) NO166409C (it)
NZ (1) NZ216552A (it)
PH (2) PH23229A (it)
ZA (1) ZA864446B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209644B (it) * 1985-06-21 1989-08-30 Isf Spa Composti farmacologicamente attivi.
FR2677984B1 (fr) * 1991-06-21 1994-02-25 Elf Sanofi Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
JP2606026B2 (ja) * 1991-07-09 1997-04-30 コクヨ株式会社 フォルダー
EP1263735B1 (en) * 2000-01-18 2007-07-04 The Regents of The University of California Acid addition salts of imidazolidinones as reaction catalysts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH470396A (de) * 1963-08-12 1969-03-31 Hoffmann La Roche Verfahren zur Herstellung von 4-Imidazolidon-Verbindungen
IT1209644B (it) * 1985-06-21 1989-08-30 Isf Spa Composti farmacologicamente attivi.

Also Published As

Publication number Publication date
US4703054A (en) 1987-10-27
DK290386A (da) 1987-02-11
JPS6230763A (ja) 1987-02-09
HUT41741A (en) 1987-05-28
EP0207680A2 (en) 1987-01-07
ZA864446B (en) 1987-03-25
KR870000305A (ko) 1987-02-17
ATE56020T1 (de) 1990-09-15
DE3673709D1 (de) 1990-10-04
CA1273450A (en) 1990-08-28
GR861578B (en) 1986-10-21
AU590283B2 (en) 1989-11-02
IT1222367B (it) 1990-09-05
FI862422A (fi) 1986-12-22
DK290386D0 (da) 1986-06-20
EP0207680A3 (en) 1989-01-18
NO166409B (no) 1991-04-08
NO862487L (no) 1986-12-22
NZ216552A (en) 1989-11-28
NO166409C (no) 1991-07-24
EP0207680B1 (en) 1990-08-29
IL79138A (en) 1991-04-15
PH23229A (en) 1989-06-06
JPH0688979B2 (ja) 1994-11-09
PH24336A (en) 1990-06-13
AU5891786A (en) 1986-12-24
FI862422A0 (fi) 1986-06-06
NO862487D0 (no) 1986-06-20

Similar Documents

Publication Publication Date Title
IT8519512A0 (it) Derivati naturali ad attivita'farmacologica
IT8448492A0 (it) Derivati di gangliosidi
DK394586D0 (da) Fungicidt aktive propenoatderivater
IT8248909A0 (it) Derivati di tiazolidinilalchilen piperazina dotati di attivita' ansiolitica e procedimento di preparazione
IT1190385B (it) Derivati di etilendiamminomonoammidi
IT1196133B (it) Derivati furanici con attivita' antiulcera
IT1187756B (it) Isoindolinil-alchil-piperazine ad attivita' farmaceutica
DK139286A (da) Inden- og naphthalenderivater
DK109186D0 (da) Dihydropyridazinonderivater
IT1203608B (it) Derivati di prolina
DK163486D0 (da) Phenylethanolaminderivater
IT1196467B (it) Derivati di diazinilpiperidina di ammidi ed immidi cicliche ad azione psicogeriatrica
DK491786D0 (da) Dichloranilinderivater
IT8521236A0 (it) Amminoacil derivati di 4(5)-imidazolidinoni ad attivita
DK556386A (da) Quinilinderivater
DE3666039D1 (de) Fulvalene derivatives
IT1199675B (it) Impiego fungicida di derivati della tetraidrobenzotienilurea
IT1200603B (it) Composizione farmaceutiche ad attivita dopaminergica
DK303886A (da) Secocanthinderivater
DE3662889D1 (de) Tetrahydrofurancarboxylic-acid derivatives
KR880700821A (ko) 데--데옥시테이코플라닌 유도체
IT8519442A0 (it) Derivati di fenilpropargilammine
IT8747901A0 (it) Derivati di cicloesanone
IT1186772B (it) Composto ad attivita' pilostimolante
IT1173454B (it) Derivati della pantetina ad attivita' antidislipemica

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950630